189 related articles for article (PubMed ID: 20858622)
1. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.
Winthrop KL; Furst DE
Ann Rheum Dis; 2010 Oct; 69(10):1735-7. PubMed ID: 20858622
[No Abstract] [Full Text] [Related]
2. Pneumococcal vaccination for RA patients on TNF-alpha antagonists.
Wright SA; Taggart AJ
Rheumatology (Oxford); 2004 Apr; 43(4):523. PubMed ID: 15024137
[No Abstract] [Full Text] [Related]
3. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
4. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
Winthrop KL
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
[TBL] [Abstract][Full Text] [Related]
5. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?
Kawakami K; Ikari K; Kawamura K; Tsukahara S; Iwamoto T; Yano K; Sakuma Y; Tokita A; Momohara S
Rheumatology (Oxford); 2010 Feb; 49(2):341-7. PubMed ID: 19965973
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.
Symmons DP; Silman AJ
Arthritis Rheum; 2004 Jun; 50(6):1703-6. PubMed ID: 15188344
[No Abstract] [Full Text] [Related]
7. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
Neven N; Vis M; Voskuyl AE; Wolbink GJ; Nurmohamed MT; Dijkmans BA; Lems WF
Ann Rheum Dis; 2005 Apr; 64(4):645-6. PubMed ID: 15769924
[No Abstract] [Full Text] [Related]
8. No link between TNF antagonists and herpes zoster.
BMJ; 2013 Mar; 346():f1432. PubMed ID: 23468293
[No Abstract] [Full Text] [Related]
9. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
Uthman I; Husari A; Touma Z; Kanj SS
Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
[No Abstract] [Full Text] [Related]
10. Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis.
Lyon CC; Thompson D
J Rheumatol; 1997 Mar; 24(3):589-91. PubMed ID: 9058671
[TBL] [Abstract][Full Text] [Related]
11. Infliximab: additional safety data from an open label study.
Daniel CL; Moreland LW
J Rheumatol; 2002 Apr; 29(4):647-9. PubMed ID: 11950000
[No Abstract] [Full Text] [Related]
12. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
13. Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?
Bongartz T; Orenstein R
Nat Rev Rheumatol; 2009 Jul; 5(7):361-3. PubMed ID: 19568250
[No Abstract] [Full Text] [Related]
14. Herpes zoster in the age of focused immunosuppressive therapy.
Whitley RJ; Gnann JW
JAMA; 2009 Feb; 301(7):774-5. PubMed ID: 19224757
[No Abstract] [Full Text] [Related]
15. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.
Curtis JR; Martin C; Saag KG; Patkar NM; Kramer J; Shatin D; Allison J; Braun MM
Arthritis Rheum; 2007 Mar; 57(2):343-6. PubMed ID: 17330283
[No Abstract] [Full Text] [Related]
16. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
Silburn S; McIvor E; McEntegart A; Wilson H
Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
[No Abstract] [Full Text] [Related]
17. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.
Wendling D; Balblanc JC; Brousse A; Lohse A; Lehuede G; Garbuio P; Toussirot E; Auge B; Jacques D
Ann Rheum Dis; 2005 Sep; 64(9):1378-9. PubMed ID: 16100348
[No Abstract] [Full Text] [Related]
18. Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?
Pappas DA; Giles JT
Curr Opin Rheumatol; 2008 Jul; 20(4):450-6. PubMed ID: 18525360
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
20. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
Kekow J; Welte T; Kellner U; Pap T
Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
